PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the
Visualization of ?-Amyloid Plaques
#MMPMID24900692
Martins AF
; Morfin JF
; Kubí?ková A
; Kubí?ek V
; Buron F
; Suzenet F
; Salerno M
; Lazar AN
; Duyckaerts C
; Arlicot N
; Guilloteau D
; Geraldes CF
; Tóth E
ACS Med Chem Lett
2013[May]; 4
(5
): 436-40
PMID24900692
show ga
In an effort toward the visualization of ?-amyloid plaques by in vivo imaging
techniques, we have conjugated an optimized derivative of the Pittsburgh compound
B (PiB), a well-established marker of A? plaques, to DO3A-monoamide that is
capable of forming stable, noncharged complexes with different trivalent metal
ions including Gd(3+) for MRI and (111)In(3+) for SPECT applications. Proton
relaxivity measurements evidenced binding of Gd(DO3A-PiB) to the amyloid peptide
A?1-40 and to human serum albumin, resulting in a two- and four-fold relaxivity
increase, respectively. Ex vivo immunohistochemical studies showed that the
DO3A-PiB complexes selectively target A? plaques on Alzheimer's disease human
brain tissue. Ex vivo biodistribution data obtained for the (111)In-analogue
pointed to a moderate blood-brain barrier (BBB) penetration in adult male Swiss
mice (without amyloid deposits) with 0.36% ID/g in the cortex at 2 min
postinjection.